Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Clinical trial NCT00886769 · TERMINATED
Trial details
- NCT number
- NCT00886769
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-12-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.